New Director Joins 1300SMILES Board of Directors

1300SMILES Ltd (ASX:ONT) is pleased to announce the appointment of Dr Glen Richards as an independent non-executive director of 1300SMILES with effect from May 2015.

Dr Richards was the founding Managing Director of Greencross (ASX: GXL) and was instrumental in building it into Australia’s largest veterinary healthcare group from 32 practices at listing to over 120 veterinary practices and 200 pet specialty stores and led its merger with Petbarn in February 2014.

During Dr Richards’s tenure Greencross Ltd has been one of the most consistent performers on the ASX in recent years with five straight years of better than 25% revenue and profit growth year on year and total shareholder returns above 1000%. Dr Richards continues as a non-executive director of Greencross.

Dr Richards is also a non-executive director of Regeneus Ltd (ASX: RGS) an ASX listed clinical-stage regenerative medicine company developing and commercialising a portfolio of cell therapies in the human and veterinary health markets with a focus on musculoskeletal disease, oncology conditions and dermatology.

1300SMILES Chairman Bob Jones said: “On behalf of the Board of Directors, I am delighted to welcome Glen to the 1300SMILES Board. Dr Richards’s extensive experience in successfully acquiring, integrating, managing and supporting a network of veterinary hospitals and pet care businesses will be invaluable and strategic to the business particularly as 1300SMILES evolves a national network of high quality dental practices.”

Dr Richards said: “I’m very pleased to join the Board of 1300SMILES and look forward to making a contribution to the growth and success of the company. 1300SMILES is a highly successful and disciplined company that has developed an excellent model for managing and supporting dental practices; I believe my experience will help support strategic plans to rapidly expand through acquisition.”